Literature DB >> 16225175

A follow-up study of infants with intracranial hemorrhage at full-term.

Balraj S Jhawar1, Adrianna Ranger, David A Steven, Rolando F Del Maestro.   

Abstract

OBJECTIVE: To determine physical and cognitive outcomes of full-term infants who suffered intracranial hemorrhage (ICH) at birth.
METHODS: A retrospective hospital-based, follow-up study of infants treated in London, Ontario between 1985 and 1996. Follow-up was conducted by telephone interviews and clinic visits. Outcome was measured according to physical and cognitive scales. Perinatal risk factors and hemorrhage characteristics were correlated with final outcome.
RESULTS: For this study 66 infants with ICH were identified, of which seven died during the first week of life. We obtained follow-up in all but ten cases (median = 3-years; range 1.0 to 10.9 years). Overall, 57% of infants had no physical or cognitive deficits at follow-up. Death occurred most frequently among those with primarily subarachnoid hemorrhage (19%) and the most favorable outcomes occurred among those with subdural hemorrhage (80% had no disability). In univariate models, thrombocytopenia (platelet count < or = 70 x 10(9)/L), increasing overall hemorrhage severity, frontal location and spontaneous vaginal delivery as opposed to forceps-assisted delivery increased risk for poor outcome. In multivariate models, all these factors tended towards increased risk, but only thrombocytopenia remained significant for physical disability (OR = 7.6; 95% CI = 1.02 - 56.6); thrombocytopenia was borderline significant in similar models for cognitive disability (OR = 4.6; 95% CI = 0.9 - 23.9).
CONCLUSION: Although forceps-assisted delivery may contribute to ICH occurrence, our study found better outcomes among these infants than those who had ICH following a spontaneous vaginal delivery. Hemorrhage in the frontal lobe was the most disabling hemorrhage location and if multiple compartments were involved, disability was also more likely to occur. However, in this report we found that the factor that was most likely to contribute to poor outcome was thrombocytopenia and this remained important in multivariate analysis.

Entities:  

Mesh:

Year:  2005        PMID: 16225175     DOI: 10.1017/s0317167100004224

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  5 in total

1.  Intrauterine grade IV intraventricular hemorrhage in a full-term infant leading to hydrocephalus.

Authors:  Christos Chamilos; Spyros Sgouros
Journal:  Childs Nerv Syst       Date:  2013-01-15       Impact factor: 1.475

2.  Management of acute subdural hematomas in infants: intrathecal infusion streptokinase for clot lysis combined with subdural to subgaleal shunt.

Authors:  Sergey N Larionov; Vladimir A Sorokovikov; Vladimir A Novozilov
Journal:  Childs Nerv Syst       Date:  2007-09-27       Impact factor: 1.475

3.  Outcome Trajectories after Primary Perinatal Hemorrhagic Stroke.

Authors:  Giulia S Porcari; Lori C Jordan; Rebecca N Ichord; Daniel J Licht; Sabrina E Smith; Lauren A Beslow
Journal:  Pediatr Neurol       Date:  2019-12-09       Impact factor: 3.372

4.  Deletion in COL4A2 is associated with a three-generation variable phenotype: from fetal to adult manifestations.

Authors:  Gustavo Malinger; Aviva Fattal-Valevski; Moran Hausman-Kedem; Liat Ben-Sira; Debora Kidron; Shay Ben-Shachar; Rachel Straussberg; Daphna Marom; Penina Ponger; Anat Bar-Shira
Journal:  Eur J Hum Genet       Date:  2021-04-09       Impact factor: 4.246

5.  The Stress and Vascular Catastrophes in Newborn Rats: Mechanisms Preceding and Accompanying the Brain Hemorrhages.

Authors:  Oxana Semyachkina-Glushkovskaya; Ekaterina Borisova; Maxim Abakumov; Dmitry Gorin; Latchezar Avramov; Ivan Fedosov; Anton Namykin; Arkady Abdurashitov; Alexander Serov; Alexey Pavlov; Ekaterina Zinchenko; Vlad Lychagov; Nikita Navolokin; Alexander Shirokov; Galina Maslyakova; Dan Zhu; Qingming Luo; Vladimir Chekhonin; Valery Tuchin; Jürgen Kurths
Journal:  Front Physiol       Date:  2016-06-14       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.